Literature DB >> 9305364

Homozygotes and heterozygotes for ciliary neurotrophic factor null alleles do not show earlier onset of Huntington's disease.

D C Rubinsztein1, J Leggo, M Chiano, S Korn, A Dodge, G Norbury, E Rosser, D Craufurd.   

Abstract

The CAG repeat number on Huntington's disease (HD) chromosomes accounts for about 60% of the variance in the age at onset of HD. However, distinct familial factors may also influence the age at onset. HD is associated with loss of medium-sized GABA-ergic striatal output neurons. Intracerebral administration of human ciliary neurotrophic factor (CNTF) protects striatal output neurons in excitotoxic rodent and primate models of HD induced by intrastriatal quinolinic acid injection. We have examined the effect of a common null mutation in the human CNTF gene on the age of onset of HD using a multiple regression approach that takes into account the CAG repeat number on HD chromosomes. We failed to detect an earlier onset of HD in nine homozygotes and 71 heterozygotes with this CNTF mutation compared with 203 homozygotes with wild-type alleles.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9305364     DOI: 10.1212/wnl.49.3.890

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  3 in total

Review 1.  Protease pathways in peptide neurotransmission and neurodegenerative diseases.

Authors:  Vivian Y H Hook
Journal:  Cell Mol Neurobiol       Date:  2006-05-25       Impact factor: 5.046

2.  Tissue-specific proteolysis of Huntingtin (htt) in human brain: evidence of enhanced levels of N- and C-terminal htt fragments in Huntington's disease striatum.

Authors:  L M Mende-Mueller; T Toneff; S R Hwang; M F Chesselet; V Y Hook
Journal:  J Neurosci       Date:  2001-03-15       Impact factor: 6.167

3.  The biological function of the Huntingtin protein and its relevance to Huntington's Disease pathology.

Authors:  Joost Schulte; J Troy Littleton
Journal:  Curr Trends Neurol       Date:  2011-01-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.